US Patent Litigations are now available. Check here

IP Verse

Maiwald patent opposition analysis

Latest oppositions filed by Maiwald

Explore patent oppositions filed by Maiwald against competitors, revealing strategic technology disputes and market positioning. Monitor opposition details, timelines, and disputed innovations to understand competitive dynamics and IP enforcement strategy.

Last updated on: Jun 26, 2025

Patent Number	Title	Applicant	Opposition Date
Get instant updates on new opposition filings by the company
EP3638243	Methods For Treating Myeloproliferative Neoplasm-Associated Myelofibrosis And Anemia	CELGENE	May 7, 2025
EP3801459	Methods Of Treating Conditions Related To The S1P1 Receptor	ARENA PHARMACEUTICALS	May 7, 2025
EP4209499	Charged Depth Filtration Of Antigen-Binding Proteins	AMGEN	May 7, 2025
EP4056712	Non-Invasive Determination Of Methylome Of Tumor From Plasma	THE CHINESE UNIVERSITY OF HONG KONG	Apr 30, 2025
EP3875085	Edaravone Suspension For Oral Administration	MITSUBISHI TANABE PHARMA	Mar 19, 2025
EP3490582	Methods And Compositions For Treating Myelofibrosis	ACCELERON PHARMA	Mar 12, 2025
EP3270966	Combination Of Hdac Inhibitor And Anti-Pd-1 Antibody For Treatment Of Cancer	SYNDAX PHARMACEUTICALS	Jan 31, 2025
EP3582814	Compounds And Methods For Treatment Of Inflammatory Bowel Disease With Extra-Intestinal Manifestations	ARENA PHARMACEUTICALS	Jan 31, 2025
EP3215166	Altering Gene Expression In Cart Cells And Uses Thereof	THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA	Jan 23, 2025
EP3090730	Novel Pharmaceutical Composition	NOVARTIS	Jan 10, 2025

Top competitors of Maiwald

AMGEN

NOVARTIS

OTSUKA PHARMACEUTICAL